News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Researcher Accuses AstraZeneca PLC (AZN) Of Manipulating Brilinta Data



2/4/2014 8:07:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In July 2011, the Food and Drug Administration approved AstraZeneca AZN.LN -0.46% PLC's anticlotting drug Brilinta for patients with certain severe coronary conditions. A study had shown the pill saved lives and reduced heart attacks—a real eye-opener in medicine. But behind the scenes, a drama is unfolding over whether the drug should have been approved.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES